LFSC F/m Emerald Life Sciences Innovation ETF

1

NASDAQ | ETF

Price
$21.72
Decreased by -4.01%
Dollar volume (20D)
68.76 K
ADR%
1.16
Healthcare - 100.00%Basic Materials - 0.00%Communication Services - 0.00%Consumer Cyclicals - 0.00%Consumer Defensive - 0.00%Energy - 0.00%Financial Services - 0.00%Industrials - 0.00%Real Estate - 0.00%Technology - 0.00%Utilities - 0.00%
Healthcare - 100.00%
Basic Materials - 0.00%
Communication Services - 0.00%
Consumer Cyclicals - 0.00%
Consumer Defensive - 0.00%
Energy - 0.00%
Financial Services - 0.00%
Industrials - 0.00%
Real Estate - 0.00%
Technology - 0.00%
Utilities - 0.00%

The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser.

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

Top 20 Holdings

Asset Name Sector Industry Weight
6XC SOLENO THERAPEUT. DL-001 Healthcare Biotechnology 7.16%
BBIO BridgeBio Pharma Inc Healthcare Biotechnology 7.06%
RDNT RadNet Inc Healthcare Diagnostics & Research 6.06%
MMSI Merit Medical Systems Inc Healthcare Medical Instruments & Supplies 6.03%
BPMC Blueprint Medicines Corp Healthcare Biotechnology 5.92%
TVTX Travere Therapeutics Inc Healthcare Biotechnology 5.32%
LIVN LivaNova PLC Healthcare Medical Devices 4.98%
COLL Collegium Pharmaceutical Inc Healthcare Drug Manufacturers - Specialty & Generic 4.73%
RARE Ultragenyx Healthcare Biotechnology 4.08%
MDGL Madrigal Pharmaceuticals Inc Healthcare Biotechnology 4.01%
INSM Insmed Inc Healthcare Biotechnology 3.90%
WVE Wave Life Sciences Ltd Healthcare Biotechnology 3.85%
ATEC Alphatec Holdings Inc Healthcare Medical Devices 3.58%
TMDX TransMedics Group Inc Healthcare Medical Devices 3.54%
GH Guardant Health Inc Healthcare Diagnostics & Research 3.39%
ITCI Intracellular Th Healthcare Drug Manufacturers - Specialty & Generic 3.16%
ETNB 89bio Inc Healthcare Biotechnology 3.02%
ACAD ACADIA Pharmaceuticals Inc Healthcare Biotechnology 2.32%
SRPT Sarepta Therapeutics Inc Healthcare Biotechnology 2.30%
AKRO Akero Therapeutics Inc Healthcare Biotechnology 2.29%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY